InvestorsHub Logo
Followers 8
Posts 450
Boards Moderated 0
Alias Born 10/04/2010

Re: None

Monday, 02/13/2017 2:53:07 PM

Monday, February 13, 2017 2:53:07 PM

Post# of 3833
After watching the CNAT presentation today I wonder why anyone would choose to hold GALT rather than CNAT.

CNAT presentation:
Efficacy on multiple trials
4 On going trials with customized end points for the targeted patients
$50M from NVTS plus lots more money and full funding of Phase 3 trials

GALT presentation:
It's a big market yadda yadda yadda
Galectins are important yadda yadda yadda
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News